Bullish
TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD (NASDAQ: TXMD) reported its first-quarter 2026 financial results, showing a net income from continuing operations of $103 thousand, a n...
Bullish
TherapeuticsMD (NASDAQ: TXMD) reported its first-quarter 2026 financial results, showing a net income from continuing operations of $103 thousand, a n...